Literature DB >> 8995582

Progressive motor neuron impairment in an animal model of familial amyotrophic lateral sclerosis.

M Azzouz1, N Leclerc, M Gurney, J M Warter, P Poindron, J Borg.   

Abstract

Mutations of Cu,Zn superoxide dismutase cause an autosomal dominant form of familial amyotrophic lateral sclerosis. An animal model of the disease has been produced by expressing mutant human SOD1 in transgenic mice (G93A). In order to quantify the dysfunction of the motor unit in transgenic mice, electromyographic recordings were performed during the course of the disease. The first alterations in neuromuscular function appeared between P63 and P90. The deficits became even more striking after P100; compound muscle action potentials in the hindlimb decreased by 80% of initial value. Spontaneous fibrillation potentials were measured in more than 50% of transgenic mice. The number of motor units in the gastrocnemius muscle was progressively reduced over time, down to 18% of the control value at P130. Moreover, distal motor latencies increased after P120. These data suggest that the initial dysfunctions of motor unit are related to a severe motor axonal degeneration, which is followed at later periods by myelin alteration.

Entities:  

Mesh:

Year:  1997        PMID: 8995582     DOI: 10.1002/(sici)1097-4598(199701)20:1<45::aid-mus6>3.0.co;2-h

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  33 in total

1.  Length-dependent axo-terminal degeneration at the neuromuscular synapses of type II muscle in SOD1 mice.

Authors:  C Tallon; K A Russell; S Sakhalkar; N Andrapallayal; M H Farah
Journal:  Neuroscience       Date:  2015-11-18       Impact factor: 3.590

2.  SOD1-G93A mice exhibit muscle-fiber-type-specific decreases in glucose uptake in the absence of whole-body changes in metabolism.

Authors:  Susan E Smittkamp; Jill K Morris; Gregory L Bomhoff; Mark E Chertoff; Paige C Geiger; John A Stanford
Journal:  Neurodegener Dis       Date:  2013-09-06       Impact factor: 2.977

3.  An acellular biologic scaffold promotes skeletal muscle formation in mice and humans with volumetric muscle loss.

Authors:  Brian M Sicari; J Peter Rubin; Christopher L Dearth; Matthew T Wolf; Fabrisia Ambrosio; Michael Boninger; Neill J Turner; Douglas J Weber; Tyler W Simpson; Aaron Wyse; Elke H P Brown; Jenna L Dziki; Lee E Fisher; Spencer Brown; Stephen F Badylak
Journal:  Sci Transl Med       Date:  2014-04-30       Impact factor: 17.956

Review 4.  Treatment of amyotrophic lateral sclerosis--what is the next step?

Authors:  A C Ludolph
Journal:  J Neurol       Date:  2000-12       Impact factor: 4.849

5.  A spastic paraplegia mouse model reveals REEP1-dependent ER shaping.

Authors:  Christian Beetz; Nicole Koch; Mukhran Khundadze; Geraldine Zimmer; Sandor Nietzsche; Nicole Hertel; Antje-Kathrin Huebner; Rizwan Mumtaz; Michaela Schweizer; Elisabeth Dirren; Kathrin N Karle; Andrey Irintchev; Victoria Alvarez; Christoph Redies; Martin Westermann; Ingo Kurth; Thomas Deufel; Michael M Kessels; Britta Qualmann; Christian A Hübner
Journal:  J Clin Invest       Date:  2013-09-24       Impact factor: 14.808

6.  Sigma-1R agonist improves motor function and motoneuron survival in ALS mice.

Authors:  Renzo Mancuso; Sara Oliván; Amaya Rando; Caty Casas; Rosario Osta; Xavier Navarro
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

7.  Circuit Dysfunction in SOD1-ALS Model First Detected in Sensory Feedback Prior to Motor Neuron Degeneration Is Alleviated by BMP Signaling.

Authors:  Aaron Held; Paxton Major; Asli Sahin; Robert A Reenan; Diane Lipscombe; Kristi A Wharton
Journal:  J Neurosci       Date:  2019-01-18       Impact factor: 6.167

8.  Motor unit number estimate as a predictor of motor dysfunction in an animal model of type 1 diabetes.

Authors:  Nizar Souayah; Joseph G Potian; Carmen C Garcia; Natalia Krivitskaya; Christine Boone; Vanessa H Routh; Joseph J McArdle
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-07-14       Impact factor: 4.310

9.  A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis.

Authors:  Carlos Riveros; Drew Mellor; Kaushal S Gandhi; Fiona C McKay; Mathew B Cox; Regina Berretta; S Yahya Vaezpour; Mario Inostroza-Ponta; Simon A Broadley; Robert N Heard; Stephen Vucic; Graeme J Stewart; David W Williams; Rodney J Scott; Jeanette Lechner-Scott; David R Booth; Pablo Moscato
Journal:  PLoS One       Date:  2010-12-01       Impact factor: 3.240

10.  Magnetic resonance imaging of mouse skeletal muscle to measure denervation atrophy.

Authors:  Jiangyang Zhang; Gang Zhang; Brett Morrison; Susumu Mori; Kazim A Sheikh
Journal:  Exp Neurol       Date:  2008-05-10       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.